TARO
Taro Pharmaceutical Industries Ltd.
TARO
TARO
Delisted
TARO was delisted on the 21st of June, 2024.
70 hedge funds and large institutions have $186M invested in Taro Pharmaceutical Industries Ltd. in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% more funds holding
Funds holding: 61 → 70 (+9)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $800K
Holders
70
Holding in Top 10
2
Calls
–
Puts
$800K
Top Buyers
| 1 | +$16M | |
| 2 | +$3.85M | |
| 3 | +$3.13M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$2.18M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.28M |
Top Sellers
| 1 | -$2.3M | |
| 2 | -$815K | |
| 3 | -$790K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$787K |
| 5 |
Millennium Management
New York
|
-$777K |